Enterostatin
Overview
WikiDoc Resources for Enterostatin |
Articles |
---|
Most recent articles on Enterostatin Most cited articles on Enterostatin |
Media |
Powerpoint slides on Enterostatin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Enterostatin at Clinical Trials.gov Clinical Trials on Enterostatin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Enterostatin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Enterostatin Discussion groups on Enterostatin Patient Handouts on Enterostatin Directions to Hospitals Treating Enterostatin Risk calculators and risk factors for Enterostatin
|
Healthcare Provider Resources |
Causes & Risk Factors for Enterostatin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Enterostatin is a pentapeptide produced from exocrine pancreas and gastrointestinal tract that selectively reduces fat intake. Its effects include a reduction of insulin secretion, an increase in sympathetic drive to brown adipose tissue, and the stimulation of adrenal corticosteroid secretion. At the end level, it initiates a sensation of fullness of stomach which could be the reason for its role in regulation of fat intake and reduction of body weight.